Home › Funds › Vestal Point Capital, LP › GMED

Vestal Point Capital, LP position in GMED

GLOBUS MED INC · Health Care

Vestal Point Capital, LP reported holding 850,000 shares of GMED (GLOBUS MED INC) in its Q2 2026 13F filing — a position valued at US$67.2M, representing 1.57% of its reported portfolio and ranking #22 among its reported holdings. Vestal Point Capital, LP has disclosed GMED holdings in 10 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)850.00K sh
Reported value held$67.16M
Portfolio Weight1.57%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's GMED position evolved

Vestal Point Capital, LP first disclosed a stake in GMED in Q4 2023 at 800,000 shares (US$42.6M). The position peaked in Q4 2025 at 1,275,000 shares, worth US$111.3M. Across 10 filings, Vestal Point Capital, LP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 850,000 shares valued at US$67.2M — an increase of 239,480 shares quarter over quarter.. Notable position changes include a 150% increase in Q2 2025 (shares fell 3% over the following quarter), a 150% increase in Q3 2025 (shares rose 52% over the following quarter), a 52% trim in Q1 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 800.00K $42.63M New
Q1 2024 1.00M $53.64M Add
Q2 2024 900.00K $61.64M Reduce
Q4 2024 325.00K $26.88M New
Q1 2025 200.00K $14.64M Reduce
Q2 2025 500.00K $29.51M Add
Q3 2025 1.25M $71.59M Add
Q4 2025 1.27M $111.32M Add
Q1 2026 610.52K $52.60M Reduce
Q2 2026 850.00K $67.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GMED and 13F data

GMED (GLOBUS MED INC) is a Health Care company. 39 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$338.1M), Sculptor Capital LP (US$237.0M), Boston Trust Walden Corp (US$124.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GMED

All GMED fund holders →

FAQ

How long has Vestal Point Capital, LP held GMED?

Vestal Point Capital, LP has disclosed GMED holdings in 10 of the last 11 reported quarters, going back to Q4 2023.

What is Vestal Point Capital, LP's current position in GMED?

As of Q2 2026, Vestal Point Capital, LP holds 850.00K shares of GMED (GLOBUS MED INC), valued at $67.16M, representing 1.57% of its reported portfolio and ranking #22.

Has Vestal Point Capital, LP been buying or selling GMED?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP increased its position in GMED. The position peaked in Q4 2025 at 1.27M shares.

Which other funds hold GMED?

Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Sculptor Capital LP, Boston Trust Walden Corp, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.